Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 22Stomach Neoplasms 3Inflammatory Breast Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Malignant mesenchymal tumor 2Lymphoma 2Liver Neoplasms 2Liposarcoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Esophageal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Neoplasms, Unknown Primary 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1

Interventions

Carboplatin 41Cisplatin 38Paclitaxel 34Specimen Handling 32Radiotherapy 27Magnetic Resonance Spectroscopy 25Gemcitabine 23Vinorelbine 15Etoposide 15Docetaxel 15Biopsy 13Pemetrexed 10Cyclophosphamide 10pembrolizumab 9Taxes 9Immunoglobulin G 9Disulfides 9Platinum 81,2-diaminocyclohexaneplatinum II citrate 8X-Rays 7Vinblastine 7Erlotinib Hydrochloride 7osimertinib 6durvalumab 6atezolizumab 6Nivolumab 6Irinotecan 6Ifosfamide 6Chemotherapy, Adjuvant 6Celecoxib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lung Neoplasms × Epirubicin × Clear all
NCT00011921 2013-09-17

Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
430 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡